THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
Ischemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formula...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Klinicist |
Subjects: | |
Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/32 |
_version_ | 1797855710642438144 |
---|---|
author | P. R. Kamchatnov A. A. Kabanov |
author_facet | P. R. Kamchatnov A. A. Kabanov |
author_sort | P. R. Kamchatnov |
collection | DOAJ |
description | Ischemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formulationcan reduce the risk of gastric mucosal lesion, has a special efficacy. The possibilities of using other antiaggregants and indirect anticoagulantsare considered. |
first_indexed | 2024-04-09T20:27:11Z |
format | Article |
id | doaj.art-f3c7f140401145edb1534c0984d2ff7f |
institution | Directory Open Access Journal |
issn | 1818-8338 |
language | Russian |
last_indexed | 2024-04-09T20:27:11Z |
publishDate | 2014-07-01 |
publisher | ABV-press |
record_format | Article |
series | Klinicist |
spelling | doaj.art-f3c7f140401145edb1534c0984d2ff7f2023-03-30T20:14:07ZrusABV-pressKlinicist1818-83382014-07-0172738010.17650/1818-8338-2013-2-73-8047THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKEP. R. Kamchatnov0A. A. Kabanov1N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaN.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaIschemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formulationcan reduce the risk of gastric mucosal lesion, has a special efficacy. The possibilities of using other antiaggregants and indirect anticoagulantsare considered.https://klinitsist.abvpress.ru/Klin/article/view/32ischemic strokesecondary preventionacetylsalicylic acidcardiomagnilwarfarin |
spellingShingle | P. R. Kamchatnov A. A. Kabanov THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE Klinicist ischemic stroke secondary prevention acetylsalicylic acid cardiomagnil warfarin |
title | THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE |
title_full | THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE |
title_fullStr | THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE |
title_full_unstemmed | THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE |
title_short | THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE |
title_sort | efficiency and safety of secondary prevention of ischemic stroke |
topic | ischemic stroke secondary prevention acetylsalicylic acid cardiomagnil warfarin |
url | https://klinitsist.abvpress.ru/Klin/article/view/32 |
work_keys_str_mv | AT prkamchatnov theefficiencyandsafetyofsecondarypreventionofischemicstroke AT aakabanov theefficiencyandsafetyofsecondarypreventionofischemicstroke AT prkamchatnov efficiencyandsafetyofsecondarypreventionofischemicstroke AT aakabanov efficiencyandsafetyofsecondarypreventionofischemicstroke |